Eudaimonia Partners LLC Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Eudaimonia Partners LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 13,599 shares of the healthcare conglomerate’s stock, valued at approximately $6,935,000. UnitedHealth Group accounts for approximately 1.2% of Eudaimonia Partners LLC’s investment portfolio, making the stock its 11th biggest holding.

Several other hedge funds have also recently added to or reduced their stakes in the business. Fairview Capital Investment Management LLC raised its holdings in UnitedHealth Group by 28.6% in the 1st quarter. Fairview Capital Investment Management LLC now owns 900 shares of the healthcare conglomerate’s stock valued at $458,000 after acquiring an additional 200 shares in the last quarter. First Manhattan Co. raised its holdings in UnitedHealth Group by 1.1% in the 1st quarter. First Manhattan Co. now owns 1,619,323 shares of the healthcare conglomerate’s stock valued at $825,808,000 after acquiring an additional 17,546 shares in the last quarter. First Republic Investment Management Inc. raised its holdings in UnitedHealth Group by 10.6% in the 1st quarter. First Republic Investment Management Inc. now owns 791,478 shares of the healthcare conglomerate’s stock valued at $403,630,000 after acquiring an additional 76,128 shares in the last quarter. Gluskin Sheff & Assoc Inc. raised its holdings in UnitedHealth Group by 11.4% in the 1st quarter. Gluskin Sheff & Assoc Inc. now owns 59,156 shares of the healthcare conglomerate’s stock valued at $30,168,000 after acquiring an additional 6,031 shares in the last quarter. Finally, Guardian Capital LP raised its holdings in shares of UnitedHealth Group by 5.8% in the 1st quarter. Guardian Capital LP now owns 56,137 shares of the healthcare conglomerate’s stock worth $28,628,000 after buying an additional 3,084 shares in the last quarter. Institutional investors own 87.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on UNH shares. SVB Leerink increased their target price on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Argus increased their target price on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a report on Monday, July 25th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price for the company. in a report on Thursday, May 26th. They noted that the move was a valuation call. Loop Capital assumed coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $585.65.

UnitedHealth Group Stock Up 1.3 %

NYSE:UNH opened at $531.25 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $496.92 billion, a P/E ratio of 27.74, a P/E/G ratio of 1.64 and a beta of 0.76. The stock’s fifty day simple moving average is $528.73 and its 200-day simple moving average is $510.59.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The firm had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period in the previous year, the company posted $4.70 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be paid a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.24%. The ex-dividend date of this dividend is Friday, September 9th. UnitedHealth Group’s dividend payout ratio is 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares in the company, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders have sold 140,324 shares of company stock valued at $75,086,185 in the last 90 days. 0.40% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.